BioLedger — Human Biospecimen Supplier from Ukraine
Ethically sourced biofluid and tissue biospecimen/s for pharma, biotech and CRO clients worldwide.
Who We Are
To accelerate global biomedical research by providing fast, reliable and fully compliant access to high-quality human biospecimens from Ukraine.
BioLedger is a compliance-first human biospecimen supplier headquartered in Ukraine. We provide pharmaceutical, biotechnology and contract research organizations worldwide with ethically sourced and clinically annotated biospecimen/s — from FFPE blocks and fresh frozen tissue to PBMC, biofluids and other sample types
We act as a structured, process-driven partner between Ukrainian clinical hospitals and international clients — not a broker, not a bulk vendor. Every biospecimen/s we deliver comes with full chain-of-custody documentation, IRB approval and a clinical data package built to your project specifications.
Learn more about usFrom request to shipment-ready biospecimen/s
A clear, five-step process built for procurement, R&D and scientific teams.
Submit Request
Share indication, sample type, and donor criteria.
Protocol Setup
BioLedger has the collection protocols and IRB approvals and ICFs.
Clinical Collection
Partnering physicians collect biospecimen/s across our Ukrainian hospital network according to the ethical regulations.
Processing & QC
Pathology review, processing, aliquoting, storage, quality check and full annotation.
Logistics
IATA P650-compliant cold chain delivery in dry ice, liquid nitrogen, or ambient temperature to any global destination.
Compliance, speed, competitive cost and wide hospital network
Compliance First
IRB-approved collection, GCP-aligned protocol, and compliant data handling built into every project from the start.
Speed
Standard project launch within approximately 1 week vs. 2–4 weeks industry average.
Cost
Ukrainian operational base keeps prices up to 30–50% lower than Western European suppliers.
Network
Partnering clinical sites across oncology, hematology and therapeutic disease areas.